Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000387
HKD
13.32
-4.72 (-26.16%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
21,654.62
26,267.02
17,605.69
21,604.31
20,890.33
24,028.02
17,230.35
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
21,654.62
26,267.02
17,605.69
21,604.31
20,890.33
24,028.02
17,230.35
Raw Material Cost
18,918.94
21,118.19
15,844.14
18,302.09
17,768.98
19,271.09
15,180.65
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
127.48
116.72
104.87
111.35
110.47
108.64
108.88
Selling and Distribution Expenses
1,988.00
2,426.28
2,202.55
1,943.30
2,098.86
2,283.73
2,006.36
Other Expenses
6.90
4.65
11.74
4.51
2.96
3.25
8.00
Total Expenditure (Excl Depreciation)
21,103.38
23,707.71
18,268.97
20,401.82
20,007.92
21,695.92
17,375.84
Operating Profit (PBDIT) excl Other Income
551.1999999999999
2559.3
-663.3
1202.5
882.4
2332.1
-145.5
Other Income
130.41
139.59
359.35
191.12
262.62
281.65
363.72
Operating Profit (PBDIT)
878.49
2,850.33
-183.92
1,564.93
1,313.97
2,756.09
-37.56
Interest
127.48
116.72
104.87
111.35
110.47
108.64
108.88
Exceptional Items
-20.16
-3.93
-9.65
1.66
-1.97
-10.26
-3.74
Gross Profit (PBDT)
2,735.68
5,148.83
1,761.55
3,302.22
3,121.35
4,756.93
2,049.70
Depreciation
281.07
275.56
262.06
261.05
257.90
255.55
245.80
Profit Before Tax
449.78
2,454.12
-560.50
1,194.19
943.63
2,381.63
-395.97
Tax
67.91
433.24
-171.96
296.66
152.09
399.38
-118.69
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
359.31
2,012.84
-358.63
867.51
749.71
1,947.30
-349.82
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
359.31
2,012.84
-358.63
867.51
749.71
1,947.30
-349.82
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
26.28
45.16
-11.49
30.91
25.51
38.64
37.60
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
385.58
2,058.00
-370.11
898.42
775.22
1,985.94
-312.22
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.16
1.13
1.11
1.09
1.1
1.07
1.06
Reserves
45,225.85
44,898.33
42,088.86
41,431.24
41,367.30
40,468.50
38,210.03
Earnings per share (EPS)
0.22
1.24
-0.22
0.53
0.46
1.2
-0.22
Diluted Earnings per share
0.22
1.24
-0.22
0.53
0.46
1.2
-0.22
Operating Profit Margin (Excl OI)
2.16%
9.27%
-4.57%
5.15%
3.8%
9.23%
-3.76%
Gross Profit Margin
3.38%
10.39%
-1.7%
6.74%
5.75%
10.98%
-0.87%
PAT Margin
1.66%
7.66%
-2.04%
4.02%
3.59%
8.1%
-2.03%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Jun 2026 is 3.66% vs 6.94% in Jun 2025

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Jun 2026 is -50.26% vs 12.85% in Jun 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Jun 2026 is -28.84% vs 10.51% in Jun 2025

stock-summary

Interest

YoY Growth in quarter ended Jun 2026 is 15.38% vs -4.25% in Jun 2025

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025

Compare Quarterly Results Of Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
21,654.62
0
21,654.62
Other Operating Income
0.00
0.00
0.00
Total Operating income
21,654.62
0
21,654.62
Raw Material Cost
18,918.94
0
18,918.94
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
127.48
0
127.48
Selling and Distribution Expenses
1,988.00
0
1,988.00
Other Expenses
6.90
0.00
6.90
Total Expenditure (Excl Depreciation)
21,103.38
0
21,103.38
Operating Profit (PBDIT) excl Other Income
551.24
0.00
551.24
Other Income
130.41
0
130.41
Operating Profit (PBDIT)
878.49
0
878.49
Interest
127.48
0
127.48
Exceptional Items
-20.16
0
-20.16
Gross Profit (PBDT)
2,735.68
0
2,735.68
Depreciation
281.07
0
281.07
Profit Before Tax
449.78
0
449.78
Tax
67.91
0
67.91
Provisions and contingencies
0
0
0.00
Profit After Tax
359.31
0
359.31
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
359.31
0
359.31
Share in Profit of Associates
0
0
0.00
Minority Interest
26.28
0
26.28
Other related items
0.00
0.00
0.00
Consolidated Net Profit
385.58
0
385.58
Equity Capital
0
0
0.00
Face Value
1.16
0
0.00
Reserves
45,225.85
0
45,225.85
Earnings per share (EPS)
0.22
0
0.22
Diluted Earnings per share
0.22
0
0.22
Operating Profit Margin (Excl OI)
2.16%
0%
0.00
2.16%
Gross Profit Margin
3.38%
0%
0.00
3.38%
PAT Margin
1.66%
0%
0.00
1.66%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 2,165.46 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -17.56% vs 49.20% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 3.66% vs 6.94% in Jun 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 38.56 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -81.26% vs 656.07% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -50.26% vs 12.85% in Jun 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 74.81 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is -72.40% vs 598.93% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is -28.84% vs 10.51% in Jun 2025

Quarterly - Interest
Interest 12.75 Million
in Jun 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2026 is 9.25% vs 11.25% in Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 is 15.38% vs -4.25% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 2.16%
in Jun 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

stock-summary

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025

Footer loading